Correction to: Imaging in staging, treatment planning, and monitoring of hepatocellular carcinoma for local and locoregional therapies: consensus recommendations from EORTC and ESGAR (European Radiology, (2025), 10.1007/s00330-025-11699-7)

Study Group

doi:10.1007/s00330-025-12045-7

Correction to: Imaging in staging, treatment planning, and monitoring of hepatocellular carcinoma for local and locoregional therapies: consensus recommendations from EORTC and ESGAR (European Radiology, (2025), 10.1007/s00330-025-11699-7)

Study Group

Radyoloji Anabilim Dalı

Heidelberg University
European Organisation for Research and Treatment of Cancer Data Center
University of Basel
European Society of Gastrointestinal and Abdominal Radiology (ESGAR)
Université libre de Bruxelles
Centre Oscar Lambret
Université de Lille
Maastricht University
RWTH Aachen University
University of Regensburg
Karolinska Institutet
IRCCS Fondazione del Piemonte per l'Oncologia - Candiolo (TO)
Fondazione Policlinico Universitario A. Gemelli IRCCS-Università Cattolica del Sacro Cuore
Catholic University of the Sacred Heart
Leipzig University
Ludwig Maximilian University of Munich
Charité – Universitätsmedizin Berlin
Klinikum Esslingen
University of Palermo
Radboud University Nijmegen
Toronto General Hospital
Hannover Medical School
University of Navarra
Klinikum Würzburg Mitte
Humanitas University
IRCCS Istituto Clinico Humanitas - Rozzano (Milano)
San Giovanni Hospital
Giresun Universitesi
University Hospitals Bristol and Weston NHS Foundation Trust
Hospital Ramon y Cajal
Leiden University
Otto von Guericke University Magdeburg
Hampshire Hospitals NHS Foundation Trust
University and Hospital Trust
KU Leuven
Ospedale del Mare
Amsterdam UMC
Niels-Stensen-Kliniken Marienhospital
University of Bern
IIS La Fe
University of Rome La Sapienza

Araştırma sonucu: Dergiye katkı › Yorum/tartışma

Özet

https://doi.org/10.1007/s00330-025-11699-7 published online 23 May 2025. In the original article, affiliation of study group member Lorenza Rimassa’s affiliation was incorrectly given as IRCCS Humanitas Research Hospital, Roma, Italy. The correct affiliation is Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano (Milan), Italy. Lorenza Rimassa is also affiliated with Department of Biomedical Sciences, Humanitas University, Pieve Emanuele (Milan), Italy, which was left out in the original article. Furthermore, the following Conflict of interest statement was missing in the original article: L.R. has received consulting fees from AbbVie, AstraZeneca, Basilea, Bayer, BMS, Elevar Therapeutics, Exelixis, Genenta, Hengrui, Incyte, Ipsen, Jazz Pharmaceuticals, MSD, Nerviano Medical Sciences, Roche, Servier, Taiho Oncology, Zymeworks; lecture fees from AstraZeneca, Bayer, BMS, Eisai, Guerbet, Incyte, Ipsen, Roche, Servier; travel expenses from AstraZeneca, Servier; and institutional research funding from AbbVie, AstraZeneca, BeiGene, Exelixis, Fibrogen, Incyte, Ipsen, Jazz Pharmaceuticals, MSD, Nerviano Medical Sciences, Roche, Servier, Taiho Oncology, TransThera Sciences, Zymeworks. The original article has been corrected.

Orijinal dil	İngilizce
Sayfa (başlangıç-bitiş)	3331-3332
Sayfa sayısı	2
Dergi	European Radiology
Hacim	36
Basın numarası	4
DOI'lar	https://doi.org/10.1007/s00330-025-12045-7
Yayın durumu	Yayınlandı - Nis 2026

BM SKH

Bu sonuç, aşağıdaki Sürdürülebilir Kalkınma Hedefine/Hedeflerine katkıda bulunur

SKH 3 Sağlık ve Kaliteli Yaşam

Belgeye Erişim

10.1007/s00330-025-12045-7

Diger dosyalar ve linkler

Link to publication in Scopus

Parmak izi

Correction to: Imaging in staging, treatment planning, and monitoring of hepatocellular carcinoma for local and locoregional therapies: consensus recommendations from EORTC and ESGAR (European Radiology, (2025), 10.1007/s00330-025-11699-7)' araştırma başlıklarına git. Birlikte benzersiz bir parmak izi oluştururlar.

Bundan alıntı yap

@article{b4d14664deb246c2969ff13e2137c005,

title = "Correction to: Imaging in staging, treatment planning, and monitoring of hepatocellular carcinoma for local and locoregional therapies: consensus recommendations from EORTC and ESGAR (European Radiology, (2025), 10.1007/s00330-025-11699-7)",

abstract = "https://doi.org/10.1007/s00330-025-11699-7 published online 23 May 2025. In the original article, affiliation of study group member Lorenza Rimassa{\textquoteright}s affiliation was incorrectly given as IRCCS Humanitas Research Hospital, Roma, Italy. The correct affiliation is Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano (Milan), Italy. Lorenza Rimassa is also affiliated with Department of Biomedical Sciences, Humanitas University, Pieve Emanuele (Milan), Italy, which was left out in the original article. Furthermore, the following Conflict of interest statement was missing in the original article: L.R. has received consulting fees from AbbVie, AstraZeneca, Basilea, Bayer, BMS, Elevar Therapeutics, Exelixis, Genenta, Hengrui, Incyte, Ipsen, Jazz Pharmaceuticals, MSD, Nerviano Medical Sciences, Roche, Servier, Taiho Oncology, Zymeworks; lecture fees from AstraZeneca, Bayer, BMS, Eisai, Guerbet, Incyte, Ipsen, Roche, Servier; travel expenses from AstraZeneca, Servier; and institutional research funding from AbbVie, AstraZeneca, BeiGene, Exelixis, Fibrogen, Incyte, Ipsen, Jazz Pharmaceuticals, MSD, Nerviano Medical Sciences, Roche, Servier, Taiho Oncology, TransThera Sciences, Zymeworks. The original article has been corrected.",

author = "\{Study Group\} and Osman {\"O}cal and Zech, \{Christoph Johannes\} and Bali, \{Maria Antonietta\} and David Pasquier and Felix Mottaghy and Ingo Einspieler and Nikolaos Kartalis and Irene Bargellini and Roberto Iezzi and Timm Denecke and Kunz, \{Wolfgang Gerhard\} and Bernhard Gebauer and Henning Wege and Roberto Cannella and Oprea-Lager, \{Daniela Elena\} and Arndt Vogel and Bruno Sangro and Max Seidensticker and Lukas Luerken and Lorenza Rimassa and Uli Fehrenbach and Christian Stroszczynski and Stefano Cappio and Serdar Aslan and Huw Roach and \{de la Pinta\}, Carolina and Mark Burgmans and Mario Venerito and John Ramage and Valeria Dionisi and Christophe Deroose and Maxime Dewulf and Cesare Guida and Bora Peynircioglu and Joost Verhoeff and Kerstin Sch{\"u}tte and Hossein Hemmatazad and Serena Pisoni and \{De Felice\}, Francesca",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2025.",

year = "2026",

month = apr,

doi = "10.1007/s00330-025-12045-7",

language = "English",

volume = "36",

pages = "3331--3332",

journal = "European Radiology",

issn = "0938-7994",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "4",

}

Correction to: Imaging in staging, treatment planning, and monitoring of hepatocellular carcinoma for local and locoregional therapies: consensus recommendations from EORTC and ESGAR (European Radiology, (2025), 10.1007/s00330-025-11699-7). / Study Group.
In: European Radiology, Hac. 36, No. 4, 04.2026, p. 3331-3332.

Araştırma sonucu: Dergiye katkı › Yorum/tartışma

TY - JOUR

T1 - Correction to

T2 - Imaging in staging, treatment planning, and monitoring of hepatocellular carcinoma for local and locoregional therapies: consensus recommendations from EORTC and ESGAR (European Radiology, (2025), 10.1007/s00330-025-11699-7)

AU - Study Group

AU - Öcal, Osman

AU - Zech, Christoph Johannes

AU - Bali, Maria Antonietta

AU - Pasquier, David

AU - Mottaghy, Felix

AU - Einspieler, Ingo

AU - Kartalis, Nikolaos

AU - Bargellini, Irene

AU - Iezzi, Roberto

AU - Denecke, Timm

AU - Kunz, Wolfgang Gerhard

AU - Gebauer, Bernhard

AU - Wege, Henning

AU - Cannella, Roberto

AU - Oprea-Lager, Daniela Elena

AU - Vogel, Arndt

AU - Sangro, Bruno

AU - Seidensticker, Max

AU - Luerken, Lukas

AU - Rimassa, Lorenza

AU - Fehrenbach, Uli

AU - Stroszczynski, Christian

AU - Cappio, Stefano

AU - Aslan, Serdar

AU - Roach, Huw

AU - de la Pinta, Carolina

AU - Burgmans, Mark

AU - Venerito, Mario

AU - Ramage, John

AU - Dionisi, Valeria

AU - Deroose, Christophe

AU - Dewulf, Maxime

AU - Guida, Cesare

AU - Peynircioglu, Bora

AU - Verhoeff, Joost

AU - Schütte, Kerstin

AU - Hemmatazad, Hossein

AU - Pisoni, Serena

AU - De Felice, Francesca

PY - 2026/4

Y1 - 2026/4

N2 - https://doi.org/10.1007/s00330-025-11699-7 published online 23 May 2025. In the original article, affiliation of study group member Lorenza Rimassa’s affiliation was incorrectly given as IRCCS Humanitas Research Hospital, Roma, Italy. The correct affiliation is Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano (Milan), Italy. Lorenza Rimassa is also affiliated with Department of Biomedical Sciences, Humanitas University, Pieve Emanuele (Milan), Italy, which was left out in the original article. Furthermore, the following Conflict of interest statement was missing in the original article: L.R. has received consulting fees from AbbVie, AstraZeneca, Basilea, Bayer, BMS, Elevar Therapeutics, Exelixis, Genenta, Hengrui, Incyte, Ipsen, Jazz Pharmaceuticals, MSD, Nerviano Medical Sciences, Roche, Servier, Taiho Oncology, Zymeworks; lecture fees from AstraZeneca, Bayer, BMS, Eisai, Guerbet, Incyte, Ipsen, Roche, Servier; travel expenses from AstraZeneca, Servier; and institutional research funding from AbbVie, AstraZeneca, BeiGene, Exelixis, Fibrogen, Incyte, Ipsen, Jazz Pharmaceuticals, MSD, Nerviano Medical Sciences, Roche, Servier, Taiho Oncology, TransThera Sciences, Zymeworks. The original article has been corrected.

AB - https://doi.org/10.1007/s00330-025-11699-7 published online 23 May 2025. In the original article, affiliation of study group member Lorenza Rimassa’s affiliation was incorrectly given as IRCCS Humanitas Research Hospital, Roma, Italy. The correct affiliation is Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano (Milan), Italy. Lorenza Rimassa is also affiliated with Department of Biomedical Sciences, Humanitas University, Pieve Emanuele (Milan), Italy, which was left out in the original article. Furthermore, the following Conflict of interest statement was missing in the original article: L.R. has received consulting fees from AbbVie, AstraZeneca, Basilea, Bayer, BMS, Elevar Therapeutics, Exelixis, Genenta, Hengrui, Incyte, Ipsen, Jazz Pharmaceuticals, MSD, Nerviano Medical Sciences, Roche, Servier, Taiho Oncology, Zymeworks; lecture fees from AstraZeneca, Bayer, BMS, Eisai, Guerbet, Incyte, Ipsen, Roche, Servier; travel expenses from AstraZeneca, Servier; and institutional research funding from AbbVie, AstraZeneca, BeiGene, Exelixis, Fibrogen, Incyte, Ipsen, Jazz Pharmaceuticals, MSD, Nerviano Medical Sciences, Roche, Servier, Taiho Oncology, TransThera Sciences, Zymeworks. The original article has been corrected.

UR - https://www.scopus.com/pages/publications/105022513943

U2 - 10.1007/s00330-025-12045-7

DO - 10.1007/s00330-025-12045-7

M3 - Comment/debate

C2 - 41171354

AN - SCOPUS:105022513943

SN - 0938-7994

VL - 36

SP - 3331

EP - 3332

JO - European Radiology

JF - European Radiology

IS - 4

ER -